- Home
- PAR vs NVCR Comparison
PAR vs NVCR Comparison
Compare PAR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAR
- NVCR
- Stock Information
- Founded
- PAR 1968
- NVCR 2000
- Country
- PAR United States
- NVCR Switzerland
- Employees
- PAR N/A
- NVCR N/A
- Industry
- PAR Office Equipment/Supplies/Services
- NVCR Medical/Dental Instruments
- Sector
- PAR Miscellaneous
- NVCR Health Care
- Exchange
- PAR Nasdaq
- NVCR Nasdaq
- Market Cap
- PAR 2.8B
- NVCR 1.9B
- IPO Year
- PAR N/A
- NVCR 2015
- Fundamental
- Price
- PAR $66.65
- NVCR $17.92
- Analyst Decision
- PAR Strong Buy
- NVCR Buy
- Analyst Count
- PAR 7
- NVCR 6
- Target Price
- PAR $79.86
- NVCR $32.83
- AVG Volume (30 Days)
- PAR 400.7K
- NVCR 1.8M
- Earning Date
- PAR 08-07-2025
- NVCR 07-24-2025
- Dividend Yield
- PAR N/A
- NVCR N/A
- EPS Growth
- PAR N/A
- NVCR N/A
- EPS
- PAR N/A
- NVCR N/A
- Revenue
- PAR $383,768,000.00
- NVCR $621,711,000.00
- Revenue This Year
- PAR $30.06
- NVCR $5.56
- Revenue Next Year
- PAR $16.97
- NVCR $9.19
- P/E Ratio
- PAR N/A
- NVCR N/A
- Revenue Growth
- PAR 37.95
- NVCR 18.27
- 52 Week Low
- PAR $43.50
- NVCR $14.17
- 52 Week High
- PAR $82.24
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- PAR 61.44
- NVCR 52.99
- Support Level
- PAR $66.09
- NVCR $16.19
- Resistance Level
- PAR $69.51
- NVCR $18.70
- Average True Range (ATR)
- PAR 1.70
- NVCR 0.77
- MACD
- PAR 0.46
- NVCR 0.09
- Stochastic Oscillator
- PAR 91.36
- NVCR 67.53
About PAR PAR Technology Corporation
PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.